Finland: Nukute appoints Lehtonen as CEO to spearhead next funding round and accelerate commercialisation

Nukute, a developer of high-tech tools for the diagnosis and testing of respiratory diseases including sleep apnea, has appointed Matti Lehtonen as CEO. He joins the company on February 1. Lehtonen joins Nukute after 14 years with GE Healthcare where he served as the GM of GE’s global Anesthesia and Respiratory Care business, and as…

You must be a HMI Subscriber to view this content.

Subscribe Now »